ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1410

Using Social Listening to Understand the Patient Voice: The Daily Impacts of Sjögren’s Disease

Zachary Cline1, Maurice Flurie1, Colton Flowers1, Enming Zhang1, Annie Lau-Kilby2, Julia Taylor2, Chiara Baldini3, Ilias Alevizo2, Kristina Davidson2, Christopher DeFelice1 and Maria Picone1, 1TREND Community, Philadelphia, PA, 2Amgen Inc., Thousand Oaks, CA, 3University of Pisa, Department of Clinical and Experimental Medicine - Rheumatology Unit, Pisa, Italy

Meeting: ACR Convergence 2024

Keywords: quality of life, Sjögren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Sjögren's Syndrome – Basic & Clinical Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Insights into the everyday burden and management of a disease relies on patient perspectives, and social media groups focused on specific diseases offer a valuable resource of authentic patient discussions to gain these insights. In particular, social media provides a platform for patients to discuss, compare, and inquire about the relationship between their condition and activities of daily living (ADLs) (e.g., physical exercise or professional activity). The aim of this study is to gain insight into the daily struggles of people living with Sjögren’s through social listening.

Methods: A proprietary text classification model for recognizing activities of daily living (ADLs) in social media conversations was applied to 84,034 posts/comments spanning over 11 years from the Reddit community r/sjogrens. Additionally, spans corresponding to clinical concepts were extracted and linked to a lexical knowledge base using a custom clinical span recognition and linking model, and emotion words/phrases were matched to one of Paul Ekman’s six primary emotions. The association between ADLs and clinical concepts/emotions was measured using PMI2. Finally, TFIDF was used to determine the non-clinical language associated with ADLs.

Results: The ADLs that were discussed most frequently were Eating & drinking (8.4% of documents), Sleeping (5.3%), and Professional activity (3.6%). Clinical concepts associated with Eating & drinking included Dryness of mouth, Saliva, Pain, and Throat; non-clinical words associated with Eating included sugar, dairy, gluten, and coffee. For Sleeping, the top associated clinical concepts were Insomnia, Sleep Apnea, and Mouth, and non-clinical words were bed, hours, morning, and water. Finally, for Professional activity, clinical concepts included Fatigue, Pain, Stress, and Exhaustion, while non-clinical language included job, full time, and home.

The strongest association identified between the six primary emotions and an ADL was between fear and Professional activity. In documents discussing Professional activity, certain words and phrases commonly appeared in those mentioning fear. These terms included symptoms, brain fog, full/part time, side effects, go back, and able [to] work.

Conclusion: Of the twelve ADLs that the model was trained to recognize, Eating & drinking was by far the most common. The clinical language associated with those documents reveal that this is likely due to the effect that dryness of mouth, a hallmark symptom of Sjögren’s, has on a patient’s comfort level during consumption. Dryness of mouth also seemed to be affecting patient’s sleep health. Finally, the clinical and non-clinical language associated with Professional activity, as well as the association with fear, suggest that a constellation of symptoms may be affecting patients’ ability to maintain employment and/or be productive at work.


Disclosures: Z. Cline: TREND Community, 3, 11; M. Flurie: TREND Community, 3, 11; C. Flowers: TREND Community, 3, 11; E. Zhang: TREND Community, 3, 11; A. Lau-Kilby: Amgen, 3, 12, stockholder; J. Taylor: Amgen, 3, 12, stockholder; C. Baldini: Amgen, 1, 2, Aurinia, 1, GlaxoSmithKlein(GSK), 2, 5, 6, 12, Paid Instructor, johnson & johnson, 1, Novartis, 5, Sanofi, 2, 6, 12, Paid Instructor, Viela, 5; I. Alevizo: Amgen, 3, 12, Stockholder; K. Davidson: Amgen, 3, 12, stock holder; C. DeFelice: TREND Community, 3, 8, 11; M. Picone: TREND Community, 3, 8, 11.

To cite this abstract in AMA style:

Cline Z, Flurie M, Flowers C, Zhang E, Lau-Kilby A, Taylor J, Baldini C, Alevizo I, Davidson K, DeFelice C, Picone M. Using Social Listening to Understand the Patient Voice: The Daily Impacts of Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/using-social-listening-to-understand-the-patient-voice-the-daily-impacts-of-sjogrens-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-social-listening-to-understand-the-patient-voice-the-daily-impacts-of-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology